Search

everythinglearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

DGAT1 enzyme helps make diacylglycerols, waxes, and retinyl esters.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

N-acetylcysteine and memantine are recommended as safe and effective treatments for trichotillomania.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Triamcinolone acetonide injections help regrow hair in alopecia areata patients.

An arthritis drug helped a person with severe hair loss regrow their hair.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

BTA safely and effectively treats hair loss, and works better with FNS.

Stress worsens Tourette symptoms by increasing allopregnanolone levels.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Activating Tgr5 may help treat hair loss and bone loss.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

Tazarotene gel may be more effective for acne than adapalene gel.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.